Integra LifeSciences (IART) Reports Prelim. Q4 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results
January 8, 2018 6:30 AM ESTPreliminary Fourth Quarter Highlights:
Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the companys previous implied guidance range of $345 million to $355 million;Organic revenue growth in the fourth quarter is expected to be about 5.5%, above the companys implied guidance of about 4%;The Company is still evaluating the impact of the Tax Cuts and Jobs Act of 2017 on its GAAP financial results;Fourth quarter 2017 adjusted earnings per share, excluding any impact from the Tax Cuts and Jobs Act of 2017, is expected to exceed the... More